Old Web
English
Sign In
Acemap
>
authorDetail
>
Mattheus Michaela
Mattheus Michaela
Type 2 diabetes
Internal medicine
Medicine
EMPA
Diabetes mellitus
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of Linagliptin versus Glimepiride on Cardiovascular Outcomes in Asians with Type 2 Diabetes-a subgroup analysis of CAROLINA
2019
Kadowaki Takashi
Yabe Daisuke
Kanasaki Keizo
Rosenstock Julio
Mattheus Michaela
Okamura Tomoo
Johansen Odd Erik
Marx Nikolaus
Show All
Source
Cite
Save
Citations (0)
Empagliflozin and Changes in Renal Function Decline in Type 2 Diabetes: Prespecified Slope Analyses from the EMPA-REG OUTCOME Trial
2017
Broedl Uli Christian
Zinman Bernard
E Inzucchi Silvio
M. Lachin John
Von Eynatten Maximilian
Koitka‐Weber Audrey
Mattheus Michaela
Bluhmki Erich
Woerle Hans-Juergen
Groop Per‐Henrik
Heerspink Hiddo Jan Lambers
Wanner Christoph
Show All
Source
Cite
Save
Citations (0)
Cardiovascular Outcomes and Mortality with Empagliflozin in Patients with Type 2 Diabetes and Prevalent Kidney Disease: Further Insights from the EMPA-REG OUTCOME trial
2017
Von Eynatten Maximilian
M. Lachin John
E Inzucchi Silvio
Fitchett David
Mattheus Michaela
Zinman Bernard
Wanner Christoph
Show All
Source
Cite
Save
Citations (0)
Rapid Onset of Renal Effects with Empagliflozin in Type 2 Diabetes: A Cumulative Renal Event Analysis over Time in EMPA-REG OUTCOME Trial
2017
Mattheus Michaela
D Schernthaner Guntram
Koitka‐Weber Audrey
Von Eynatten Maximilian
E Cooper Mark
Wanner Christoph
Show All
Source
Cite
Save
Citations (0)
1